The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effectiveness and safety of eribulin therapy in HR-positive HER2-negative metastatic breast cancer post-CDK4/6 inhibitor therapy in Russian clinical practice.
 
Irina Vladimirovna Kolyadina
No Relationships to Disclose
 
Larisa Bolotina
No Relationships to Disclose
 
Lyudmila Zhukova
No Relationships to Disclose
 
Liubov Yu Vladimirova
No Relationships to Disclose
 
Alexander Sultanbaev
No Relationships to Disclose
 
Elena Karabina
No Relationships to Disclose
 
Inna Ganshina
No Relationships to Disclose
 
Elena Ovchinnikova
No Relationships to Disclose
 
Galina Antonova
No Relationships to Disclose
 
Mikhail Volkonsky
No Relationships to Disclose
 
James Kolokolov
No Relationships to Disclose
 
Elena Zueva
No Relationships to Disclose
 
I Akopyan
No Relationships to Disclose
 
Natalia Fadeeva
No Relationships to Disclose
 
Irina Evstigneeva
No Relationships to Disclose
 
Svetlana Orlova
No Relationships to Disclose
 
Anna Vasilevskaya
No Relationships to Disclose
 
Oxana Shalaeva
No Relationships to Disclose
 
Oxana Shirokova
No Relationships to Disclose